abstract |
A compound having the general structure of Formula (I): n nor a pharmaceutically acceptable salt, solvate, ester, or tautomer thereof, wherein: n nQ is selected from the group consisting of: n nand n nL is selected from the group consisting of: n nor a pharmaceutically acceptable salt, solvate, ester, or tautomer thereof, are useful in treating diseases, disorders, or conditions such as metabolic syndrome and dyslipidemia. |